YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Martin Shkreli heads into fraud trial

Posted online
Pharmaceutical entrepreneur Martin Shkreli is headed to trial today.

Known for raising the price of a life-saving drug by 5,000 percent, Shkreli is accused of running a Ponzi-like scheme at his former hedge fund and a drug company he once ran.

The charges are not related to his infamous move to raise the price of anti-parisitic drug Daraprim to $750 a pill from $13.50 in 2015.

Read more from Reuters.


Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences